SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (16743)5/10/2005 10:04:21 AM
From: former_pgs  Read Replies (1) | Respond to of 52153
 
I agree with you.

11% of 40 patients is 4.4 patients. 22% of 40 patients is 8.8 patients.

The numbers don't make sense, but I suspect that not all of the 40 patients had measurable disease?

One thing that is not clear to me from this PR is what criteria they used for objective response. RECIST or CA-125? If I'm right about the above comment regarding measurable disease, I may have answered my own question. But it would be good to know, regardless.



To: Biomaven who wrote (16743)5/10/2005 2:11:45 PM
From: zeta1961  Read Replies (2) | Respond to of 52153
 
11% responding..just like 2.2 kids/household?<g>

OT: God, I'm having terrible lower back pain today(I've managed to avert this problem!)..while bathing the pup, reached over too far...I was contemplating going to the ER last night to r/o fracture/displacement it was so acute..any pointers?..gotta' get on a plane in 24 hours..thanks Peter..

Zeta


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News